Pure Research Compounds, Peak Integrity.
Pharmaceutical-grade 99.8% HPLC-certified research peptides, dual-action Tirzepatide and Retatrutide metabolic reserves, Alluvi dial-a-dose subcutaneous injection devices, and lyophilized bioregenerative complexes. Every synthesis batch is cold-chain monitored at 2 to 8°C with certified mass spectrometry assays for precision laboratory protocols.
- Batch VerifiedThird-party tested
- 99%+ PurityHPLC and Mass Spec
- 50mg VialLyophilized powder
- COA IncludedPer-batch report
Discover Our Most-Loved Products
High-demand synthetic peptide sequences and prefilled subcutaneous devices, third-party verified for 99%+ HPLC purity and zero degradation.
Alluvi Retatrutide 40mg Dial-a-Dose Subcutaneous Device
Factory-calibrated multi-dose subcutaneous injector pen loaded with 40mg pure GLP-1/GIP/Glucagon triple agonist.
Tirzepatide & Retatrutide Dual-Action Research Reserve (TR-20 & RT-20)
Multi-agonist research suite featuring 20mg Tirzepatide, 20mg Retatrutide, 10mg BPC-157, and sterile reconstitution solution.
Featured Inventory Preview
Tirzepatide & Retatrutide Dual-Action Research Reserve (TR-20 & RT-20)
Alluvi Retatrutide 40mg Dial-a-Dose Subcutaneous Device
Retatrutide 40mg & BPC-157/TB-500 Dual-Device Protocol Pack
Clinical Multi-Compound Research Portfolio (50 Vials Total)
HPLC Lab Certified
Every lot is third-party tested with high performance liquid chromatography.
Cleanroom Specification
Sterile environment handling following rigorous laboratory protocols.
Insulated Packaging
Temperature-controlled thermal packaging to preserve compound stability.
Priority Dispatch
Rapid same-day dispatch with end-to-end discrete tracking.
Inquiries regarding peptide reconstitution, sterile storage, or cold-chain transit?
Review certified HPLC analysis protocols, bacteriostatic water dilution ratios, freezer storage parameters, and thermal-insulated priority packaging.